Sharmaine Lau and S.K. Leong spent years searching for a name to explain why their son, Matthew, was slipping away. He had been a content, smiling toddler, but by age five, the milestones he had once met began to vanish. The diagnosis, when it finally arrived, was not a solution but a sentence: Sanfilippo syndrome.

Often described as "childhood dementia," Sanfilippo syndrome is a rare, brutal genetic disorder that progressively destroys brain cells. For the Leong family, the diagnosis was only the beginning of a long, agonizing journey that would eventually claim their younger son, Isaac, and leave Matthew, now 29, in need of constant, specialized care.

The Biological Mechanism of Decay

Sanfilippo syndrome, or mucopolysaccharidosis type III, is an inherited metabolic condition. It occurs when both parents carry a faulty gene that prevents the body from producing the enzymes necessary to break down heparan sulfate, a complex sugar.

"When these enzymes do not work properly, this sugar builds up in cells throughout the body, particularly in the brain," explains Professor Denise Goh, who heads the division of genetics and metabolism at the National University Hospital’s Khoo Teck Puat-National University Children’s Medical Institute. This accumulation triggers chronic inflammation and progressive cellular destruction, effectively reversing the cognitive and motor development of a child.

A Diagnostic Odyssey

Because the condition is not routinely included in standard newborn screening programs, many families endure years of misdiagnosis. Matthew was initially flagged for attention deficit hyperactivity disorder (ADHD) and later autism, as his symptoms—hyperactivity, cognitive plateaus, and fixation on mechanical objects—mimicked more common developmental conditions.

It was only when the regression became undeniable that the family sought genetic testing. By the time Isaac, born six years after Matthew, began showing similar signs of being non-verbal, the family already knew the path they were on. Isaac passed away in 2022 at age 19 due to a lung infection, a common complication in the late stages of the disease.

The Limits of Current Care

There is currently no cure for Sanfilippo syndrome. Clinical management is strictly palliative, focusing on symptom control and maintaining the patient's quality of life through multidisciplinary teams.

"Children typically appear completely normal at birth and throughout early infancy," Prof. Goh notes. "The first signs usually do not become noticeable until around one to four years of age." Because of this silent onset, the development of new, early-detection screening methods remains the most critical frontier for families with a history of the condition.

What Experts Say

Medical professionals emphasize that while the disease is devastating, the role of supportive care cannot be overstated. Palliative care services, such as Star PALS (Paediatric Advanced Life Support), provide essential relief for families navigating the physical and emotional toll of the syndrome.

Researchers are currently investigating potential gene therapies, though these remain in experimental stages. For now, the focus remains on managing the three distinct stages of the disease—early, middle, and late—to provide comfort as cognitive and motor functions decline.

Key Takeaways

  • Sanfilippo syndrome is a rare metabolic disorder caused by the body's inability to break down heparan sulfate, leading to progressive brain cell damage.
  • Early symptoms often mimic autism or ADHD, leading to significant diagnostic delays that prevent early intervention.
  • While there is no cure, multidisciplinary supportive care and palliative services are essential for managing the quality of life for those affected.

As researchers continue to refine newborn screening protocols, the next major milestone for the community will be the publication of long-term data from ongoing gene therapy trials. For families like the Leongs, the focus remains on the daily reality of care, waiting for the day when a diagnosis no longer carries the weight of an inevitable decline.